SCHEMBL4262345

SCHEMBL4262345

COc1ccccc1-c1ccc2c(c1)c1cc(-c3cc4c5cc(-c6ccccc6OC)ccc5n(CCC(C)CCCC(C)C)c4cc3OCCC(C)CCCC(C)C)c(OCCC(C)CCCC(C)C)cc1n2CCC(C)CCCC(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSPO P30536 1/20 0.41
ICMT O60725 6/20 0.39
CYP1A2 P05177 7/20 0.36
CYP3A4 P08684 7/20 0.36
CYP2D6 P10635 7/20 0.36
CYP2C19 P33261 7/20 0.36
ALDH1A1 P00352 6/20 0.36
LMNA P02545 6/20 0.36
TSHR P16473 5/20 0.36
CLK4 Q9HAZ1 5/20 0.36
HSD17B10 Q99714 5/20 0.36
KDM4E B2RXH2 3/20 0.35
MAPT P10636 1/20 0.35
KCNH2 Q12809 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
MAP4K4 O95819 1/20 0.34
USP2 O75604 4/20 0.34
MAPK1 P28482 4/20 0.34
HIF1A Q16665 3/20 0.34
CYP2C9 P11712 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4260558 0.85 PSEN1 (0.43) ALDH1A1LMNAMAPTHPGDPSEN1
SCHEMBL4262350 0.85 TSPO (0.38) TSPOICMTCYP1A2CYP3A4CYP2D6
SCHEMBL4267403 0.84 MAPT (0.39) TSPOICMTALDH1A1KDM4EMAPT
SCHEMBL4267813 0.81 SIGMAR1 (0.38) ALDH1A1MAPTPSEN1PSEN2APH1B
SCHEMBL4261403 0.81 MAPT (0.43) ALDH1A1LMNAKDM4EMAPTPSEN1
SCHEMBL4254141 0.79 MAPT (0.39) ALDH1A1KDM4EMAPTPSEN1PSEN2
SCHEMBL4261394 0.77 SIGMAR1 (0.39) TSPOCYP1A2CYP2C19ALDH1A1TSHR
SCHEMBL4256948 0.75 PSEN1 (0.42) ALDH1A1LMNAMAPTHPGDPSEN1
SCHEMBL4971891 0.75 PSEN1 (0.31) PSEN1
SCHEMBL4267934 0.75 MAPT (0.42) ALDH1A1LMNAKDM4EMAPTPSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090242876-A1 CARBAZOLE COMPOUNDS KONINKLIJKE PHILIPS ELECTRONICS, N.V. (NL) 2009-10-01 US disclosed
EP-1838671-B1 9,9'- AND 2,2'-SUBSTITUTED 3,3'-BICARBAZOLYL DERIVATIVES FOR USE IN SEMICONDUCTING MATERIALS AS A HOST MATRIX FOR PHOSPHORESCENT EMITTERS KONINKL PHILIPS ELECTRONICS NV (NL) 2008-06-04 EP disclosed
EP-1838671-A2 9,9'- AND 2,2'-SUBSTITUTED 3,3'-BICARBAZOLYL DERIVATIVES FOR USE IN SEMICONDUCTING MATERIALS AS A HOST MATRIX FOR PHOSPHORESCENT EMITTERS Koninklijke Philips Electronics N.V. (NL) 2007-10-03 EP disclosed
WO-2006061759-A2 9 , 9 ' - AND 2 , 2 ' -SUBSTITUTED 3 , 3 ' -BICARBAZOLYL DERIVATIVES FOR USE IN SEMICONDUCTING MATERIALS AS A HOST MATRIX FOR PHOSPHORESCENT EMITTERS KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) 2006-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090242876-A1 CARBAZOLE COMPOUNDS CCNI, IL33, PAICS TSPO 2801/4885ICMT 142/4885CYP1A2 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.